ABBV vs MRK
AbbVie Inc · Merck & Company Inc
Relative return (rebased to 100)
Key stats
| Metric | ABBV | MRK |
|---|---|---|
| Price | $248.78 | $148.46 |
| Market Cap | $439.62B | $366.28B |
| P/E | 104.03 | 20.07 |
| P/B | — | 8.73 |
| P/S | 7.19 | 5.63 |
| ROE | — | 43.5% |
| Net Margin | 6.9% | 28.1% |
| Gross Margin | — | — |
| Revenue Growth | 8.6% | 1.3% |
| Dividend Yield | 2.67% | 2.21% |
| EPS | $2.39 | $7.40 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.